Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 1/20 | 0.35 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.35 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.35 |
| ▸ | OPRK1 | P41145 | 3/20 | 0.35 |
| ▸ | CASR | P41180 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5245866 | 0.86 | OPRM1 (0.38) | BCHEOPRM1OPRD1OPRK1CASR | |
| SCHEMBL5137499 | 0.86 | HSD11B1 (0.36) | BCHEOPRM1OPRD1OPRK1CASR | |
| SCHEMBL5152777 | 0.81 | OPRM1 (0.36) | BCHEOPRM1OPRD1OPRK1CASR | |
| SCHEMBL5153427 | 0.80 | MEN1 (0.37) | BCHEOPRM1OPRD1OPRK1CASR | |
| SCHEMBL5135358 | 0.76 | HSD11B1 (0.42) | BCHEOPRM1OPRD1OPRK1HSD11B1 | |
| SCHEMBL5075147 | 0.74 | TSHR (0.39) | MEN1KMT2AHSD11B1CYP3A4ALDH1A1 | |
| SCHEMBL5136725 | 0.74 | C5AR1 (0.55) | LMNAALDH1A1TSHR | |
| SCHEMBL5135094 | 0.73 | HSD11B1 (0.40) | BCHEOPRM1OPRD1OPRK1HSD11B1 | |
| SCHEMBL5136922 | 0.73 | KDM4E (0.35) | CYP3A4ALDH1A1TSHR | |
| SCHEMBL5136012 | 0.73 | MEN1 (0.39) | MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1490044-A4 | COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS | NEUROGEN CORP (US) | 2008-04-16 | — | — | EP | disclosed |
| EP-1490044-A1 | COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS | NEUROGEN CORPORATION (US) | 2004-12-29 | — | — | EP | disclosed |
| WO-2003084524-A1 | COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS | NEUROGEN CORPORATION (US) | 2003-10-16 | — | — | WO | disclosed |